Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 1997

View Archived Issues

Immune Response's TCR vaccine evaluated in MS patients

Parke-Davis initiates QUASAR trial of quinapril

Dovetail issued patent for Betathine

Pacific Pharmaceuticals and Steri-Oss sign distribution agreement

Familial Mediterranean fever gene discovered

Neurochemical actions of ARL-12495AA, the active metabolite of remacemide

Antiarrhythmic effects of 5-HT2 antagonist/TxA2 antagonist combination investigated

BMS reports new cephalosporins active against MRSA

Tasmar approved in EU for Parkinson's disease

Gensia's injectable diltiazem receives ANDA approval

Roche withdraws NDA for orlistat

FDA approves Hi-Tech's generic promethazine/codeine syrup

Marketing agreement reached for Abelcet in France and Italy

Eurand and Global enter pancrelipase agreement

Canadian marketing clearance granted for Emdogain

Morphine derivatives discovered by Nycomed

FDA approves nonsurgical treatment for BPH

ImmunoGen's apoptosis research receives patent protection

Alza will acquire Therapeutic Discovery Corporation

Val-HeFT will evaluate valsartan in CHF

New Parkinson's disease treatment option now available in Canada

New indication approved for Asacol

First regulatory submission filed for Macritonin

CURVES study results point in favor of atorvastatin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.